Ionis Pharmaceuticals | IONS - Ebitda

Aktienkurs
72.46
Täglich Wechseln
1.27 1.78%
Monatlich
-10.94%
Jährlich
111.25%
Q1 Prognose
69.04




Ebitda Veränderung Datum
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Astellas Pharma JPY 183.68B 31.98B 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Exelixis USD 248.93M 28.02M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 15.51M 3.39M 2025-06
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Omeros USD -47.96M 7.39M 2023-09
OPKO Health USD 75.53M 144.7M 2025-09
Organigram Holdings CAD 6.15M 455K 2025-09
Pfizer USD 6.08B 351M 2025-09
Pharma Mar EUR 44.96M 46.94M 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Qiagen NV USD 249.69M 56.53M 2025-12
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06